ArticleESMO real world data and digital oncology2025

Clinical decision impact of HER2DX, an algorithm-powered genomic diagnostic in early-stage HER2-positive breast cancer: results from a prospective real-world study.

O Martínez-Sáez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.